NAT9

Across TCGA patient cohorts, NAT9 mutation is significantly associated with the immune_cell of many other genes, with 1 significant associations in total. BLCA shows the largest number of these associations.

The most reproducible NAT9-associated genes across cancer lineages are CD4+ Tcm. Each is linked with NAT9 in more than 1 cancer types. Because this analysis shows association rather than direction, both NAT9-to-partner and partner-to-NAT9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, CD4+ Tcm grouped by NAT9-low versus NAT9-high in BLCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NAT9→partner) and Y-score (partner→NAT9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BLCA	CD4+ Tcm →	+0.041	+3.527	<.001	.033	3	2

Each partner links to its Q-omics profile. Showing the 1 strongest of 1 associations by consensus.

CD4+ Tcm by NAT9 expression — BLCA

Explore this box plot interactively →